On August 7, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant drug pricing-related provisions. The bill generally revives many of the drug pricing provisions...more
The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more
4/26/2021
/ Biden Administration ,
Critical Infrastructure Sectors ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part D ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda
In his first significant legislative achievement in office, President Biden quickly signed the American Rescue Plan, legislation passed by Congress providing $1.9 trillion in coronavirus relief to Americans and businesses...more
3/12/2021
/ Agribusiness ,
American Rescue Plan Act of 2021 ,
Biden Administration ,
CARES Act ,
Child Tax Credit ,
COBRA ,
Coronavirus/COVID-19 ,
Financial Stimulus ,
Infectious Diseases ,
Medicare ,
Multiemployer Plan ,
Paycheck Protection Program (PPP) ,
Relief Measures ,
Rental Assistance Programs ,
SNAP Program ,
Tribal Governments ,
Unemployment Benefits